Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CSER _CC_NCGL, |
RCV000210890 | SCV000264595 | likely benign | Malignant hyperthermia of anesthesia | 2015-12-01 | criteria provided, single submitter | research | |
Illumina Laboratory Services, |
RCV000366145 | SCV000353111 | benign | Hypokalemic periodic paralysis, type 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Gene |
RCV000548603 | SCV000523542 | likely benign | not provided | 2020-10-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26994242, 28326467, 28259615) |
Labcorp Genetics |
RCV001086299 | SCV000653641 | benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454557 | SCV004179083 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003454558 | SCV004179084 | likely benign | Thyrotoxic periodic paralysis, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003458355 | SCV004179085 | likely benign | Congenital myopathy 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000366145 | SCV004179086 | likely benign | Hypokalemic periodic paralysis, type 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV003454557 | SCV004360387 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2022-09-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003907784 | SCV004718241 | benign | CACNA1S-related disorder | 2023-06-14 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |